AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a pre-clinical mouse model of congenital generalised lipodystrophy.

Sommer N, Roumane A, Tiwari M, Han W, Heisler LK, Mcilroy GD, Rochford JJ

Open source

DOI
10.1038/s41434-026-00646-w
Published
2026 Oct 23
Container
Gene therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41434-026-00646-w,
  title = {AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a pre-clinical mouse model of congenital generalised lipodystrophy.},
  author = {Sommer N and Roumane A and Tiwari M and Han W and Heisler LK and Mcilroy GD and Rochford JJ},
  year = {2026},
  journal = {Gene therapy},
  doi = {10.1038/s41434-026-00646-w},
  url = {https://doi.org/10.1038/s41434-026-00646-w}
}

RIS

TY  - JOUR
TI  - AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a pre-clinical mouse model of congenital generalised lipodystrophy.
AU  - Sommer N
AU  - Roumane A
AU  - Tiwari M
AU  - Han W
AU  - Heisler LK
AU  - Mcilroy GD
AU  - Rochford JJ
PY  - 2026
JO  - Gene therapy
DO  - 10.1038/s41434-026-00646-w
UR  - https://doi.org/10.1038/s41434-026-00646-w
ER  - 

APA

N, S., A, R., M, T., W, H., LK, H., GD, M., & JJ, R. (2026). AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a pre-clinical mouse model of congenital generalised lipodystrophy.. Gene therapy. https://doi.org/10.1038/s41434-026-00646-w

Source records